Cargando…
Comorbidities increase in-hospital mortality in dengue patients in Brazil
Dengue remains an unmet public health burden. We determined risk factors for dengue in-hospital mortality in Brazil. Of 326,380 hospitalised dengue cases in 9-45-year-old individuals, there were 971 deaths. Risk of dying was 11-times higher in the presence of underlying common comorbidities (renal,...
Autores principales: | Werneck, Guilherme L, Macias, Alejandro E, Mascarenas, Cesar, Coudeville, Laurent, Morley, David, Recamier, Vincent, Guergova-Kuras, Mariana, Puentes-Rosas, Esteban, Baurin, Nicolas, Toh, Myew-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056917/ https://www.ncbi.nlm.nih.gov/pubmed/30043823 http://dx.doi.org/10.1590/0074-02760180082 |
Ejemplares similares
-
Mortality among Hospitalized Dengue Patients with Comorbidities in Mexico, Brazil, and Colombia
por: Macias, Alejandro E., et al.
Publicado: (2021) -
Hospital admissions with influenza and impact of age and comorbidities on severe clinical outcomes in Brazil and Mexico
por: El Guerche-Séblain, Clotilde, et al.
Publicado: (2022) -
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine: Randomized Phase IIIb Trial in Healthy Participants 9–60 Years of Age in the Philippines
por: Santos, Jaime, et al.
Publicado: (2021) -
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Quadrivalent Human Papillomavirus Vaccine in Boys and Girls 9–13 Years of Age in Malaysia: A Phase IIIb, Randomized, Open-label Study
por: Hassan, Jamiyah, et al.
Publicado: (2021) -
Transmission Dynamics of the Four Dengue Serotypes in Southern Vietnam and the Potential Impact of Vaccination
por: Coudeville, Laurent, et al.
Publicado: (2012)